News & Media

About Abiomed

Based in Danvers, Massachusetts, USA, Abiomed, Inc., part of Johnson & Johnson MedTech, is a leading provider of medical technology that provides circulatory support and oxygenation. Our products are designed to enable the heart to rest and recover by improving blood flow and/or provide sufficient oxygenation to those in respiratory failure.

View all press releases

Illustration of a heart with an Impella RP in the right ventricle and Impella CP with SmartAssist in the left ventricle

Media Center for Journalists

Abiomed’s media kit provides a comprehensive source of information for you to tell your story, from product images to b-roll video.

News & Media Relations Contact

Jenny Leary, Associate Director, U.S. Communications

[email protected]

(978) 882-8491


Impella® Heart Pumps

Impella heart pumps are the only U.S. Food and Drug Administration-approved percutaneous heart pump technology indicated for patients with severe coronary artery disease requiring high-risk PCI or treatment of AMI cardiogenic shock. Impella has the unique ability to enable your heart to recover, allowing patients to return home from the hospital with their native hearts.

Image of the Abiomed Breethe OXY-1 System console on a navy background with a blue hash pattern overlay

Abiomed Breethe OXY-1 System™ is an easy-to-use, compact cardiopulmonary support system, with an integrated oxygen concentrator that provides an independent oxygen source designed to support mobility.


Patient Stories of Heart Recovery

Our patients are the motivation for all that we do, and we take great joy in celebrating every patient’s success story. Explore the unique stories of people with complex heart disease and advanced heart failure who were able to recover their own hearts.